ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Moxibustion treatment for Parkinson's disease: study protocol for a randomized controlled trial

Wu, Chunxiao; Zhao, Lijun; Guo, Yuelin; Hao, Xiaoqian; Fan, Yaohua; Wu, Peipei; Han, Jiajun; Li, Qinglian; Wang, Xiaoling; Wang, Qizhang; Luo, Xiaodong*; Zhu, Meiling*广州中医药大学
BMC Complementary Medicine and Therapies2023-6-12DOI: 10.1186/s12906-023-03995-w
25阅读
引用收藏
分享

摘要

BackgroundParkinson's disease (PD) is the second most common neurodegenerative disorder and seriously affects quality of life globally. Moxibustion is widely used to treat neurodegenerative diseases in the clinic and has achieved a beneficial clinical effect. However, strict control and high-quality randomized controlled trials are still lacking. Therefore, this trial aims to evaluate the clinical efficacy and safety of moxibustion in patients with PD and preliminarily explore the underlying mechanism.MethodsThis is a randomized, single-blind and placebo-controlled trial design in which 70 eligible participants will be randomly divided into a moxibustion group and a sham moxibustion group. Baihui (DU20) and Sishenchong (EX-HN1) are selected for both groups. The treatment will be performed for 30 min per session, two sessions a week for 8 weeks. The mean change in MDS-UPDRS scores (including MDS-UPDRS II, III subscale scores and total scores) from baseline to the observation points will be the primary outcome. The secondary outcomes will include scores on the Parkinson's Disease Questionnaire-39 (PDQ-39), Fatigue Severity Scale (FSS), Parkinson Disease Sleep Scale (PDSS), Montreal Cognitive Assessment (MoCA), and Self-Rating Depression Scale (SDS) as well as the Wexner constipation score. All the above outcomes will be assessed at 4 and 8 weeks. Laboratory blood biochemical analysis and functional magnetic resonance imaging (fMRI) will be conducted at baseline and at the end of treatment to explore the potential mechanisms of moxibustion in regulating PD.DiscussionIn conclusion, the results of this trial will reveal whether moxibustion is effective for treating motor and nonmotor symptoms in PD. This trial will also preliminarily explore the underlying mechanism of the regulatory effect of moxibustion in PD, which will contribute to providing a theoretical basis for the treatment of PD.

学科与关键词

关键词
MoxibustionParkinson's diseaseProtocolRandomized controlled trial
相关
加载中…
  • Effects of Qihuang Needling on Motor Function for Patients With Parkinson's Disease: Study Protocol for a Multicenter, Randomized Controlled Trial
    Yang, Lian-Sheng; Li, Yang-Mei; Zhou, Dan-Feng; Zhao, Bai-Ming; Zheng, Shu-Zhen; Chen, Zhen-Hu; Zhang, Kun*; Lu, Li-Ming*Frontiers in Neurology, 2022, 13: 902170.被引 2
  • A study on the effects of the Qihuang Needle therapy on patients with Parkinson's disease
    Li, Xinyu; Zhou, Jingpei; He, Renxiu; Lian, Jiahui; Jia, Jie; Hsu, Chialin; Yuan, Shihua; Chen, Zhenhu*Frontiers in Neurology, 2023, 13: 1022057.
  • Efficacy of Acupuncture for Parkinson's Disease Anxiety: Two-Stage Protocol for a Randomized Controlled Clinical Trial
    Fan, Jing-Qi; Xu, Zi-Qiao; Chen, Yuan-Yuan; Lu, Wei-Jing; Xie, Xiao-Yan; Wang, Yu-Ting; Zhuang, Li-Xing*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5180193.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Complementary Medicine and Therapies
发表日期
2023-06-12
卷期
第 23 卷, 第 1 期
页码
193
DOI
10.1186/s12906-023-03995-w
成果收录
SCIE

作者

  • W

    Wu, Chunxiao (第一作者)

    guangzhou univ chinese med

  • Z

    Zhao, Lijun

查看全部 12 位作者收起作者
  • G

    Guo, Yuelin

  • H

    Hao, Xiaoqian

  • F

    Fan, Yaohua

  • W

    Wu, Peipei

  • H

    Han, Jiajun

  • L

    Li, Qinglian

  • W

    Wang, Xiaoling

  • W

    Wang, Qizhang

  • L

    Luo, Xiaodong (通讯)

    2 · guangzhou univ chinese med

  • Z

    Zhu, Meiling (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417